3091-3100 of 4059 results
Revision of Indonesia's Negative Investment List
On 11 February 2016 the Indonesian Government released the tenth instalment of its economic stimulus programme The programme includes new regulations that seek to streamline investment and business licence procedures and weaken the hold of oligarchies and cartels that exist in certain sectors The ...
Financial Services Class Actions
Our class actions team recently published our Class Action Risk 2016 report The objective of the report is to look behind the headlines and hype that often surrounds class actions to provide a more holistic and objective assessment of class action risk for our clients This is particularly important ...
Improving the role of the Appointed Actuary
APRA is seeking to improve the role of the Appointed Actuary in general and life insurance companies and has proposed some reforms in a discussion paper released earlier this year ...
The High Court has its say on penalties
The high court handed down its decision in Paciocco v Australia and New Zealand banking group limited. ...
Workplace Relations
In this issue we look at the problems of overselling a companys performance to attract new staff new Federal Government policy that will make franchisors and parent companies responsible for their franchisees and subsidiaries breaches of the Fair Work Act and the importance of following procedural ...
Beware the risks of converting casuals to permanent employees
A Full Bench of the Fair Work Commission has ruled that prior service as a casual counts as service when calculating redundancy pay The decision is completely at odds with what employers would expect Partner Simon Dewberry Managing Associate Andrew Stirling and Senior Associate Tristan Garcia ...
What's in a (biosimilar) name?
Because biosimilars and their reference biologic medicine are not identical whether compared to each other or even between biosimilars it is important to know which product has been used ...
Protecting investment in biologic medicines - biological medicines, biosimilars and the challenges they pose
This series of articles is directed towards the part of biotech that is pharmaceutical rather than diagnostic or bioengineering technologies and in particular towards biologic medicines ...
Coming this spring: ACCC to monitor large merchants' payment surcharges
The Reserve Bank has now released a Standard which sets out what payment surcharges will be permitted for the purposes of the new Part IVC of the Competition and Consumer Act 2010 Cth The aim of the Standard is to improve competition and efficiency by providing to consumers price signals associated ...
Not better late - the Prime Trust appeal judgment
The main Prime Trust appeal judgement is relatively well known but a trusts responsible entities and their officers should look at what the appeal court had to say on other related matters ...